BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 11, 2002
View Archived Issues
Kudos Raises £30M For Clinical Development Of Cancer Drugs
LONDON - Kudos Pharmaceuticals Ltd. raised £29.5 million (US$45.9 million) in third-round funding with plans to take its two lead cancer treatments through Phase II and push further compounds into Phase I. (Bioworld International
Read More
With New Premises, Tropos Launches € 15M Funding Round
No Abstract
Read More
Gene Deletion From Colorectal Tumors Might Dictate Success
Read More
Session Examines Avoiding Legal Pitfalls In Clinical Trials
Read More
Committee Provides Support For European Biotechnology
Read More
EU Legislation On GMO Exports Weak, Parliament Member Says
Read More
Medivir To Lose CEO Frick To Venture Capital Fund
Read More
MediGene Reports Positive Early Results In Liver Cancer
Read More
Avidex Third Round Raises £11.5M For T-Cell Receptors
Read More
New Controls On Genetically Modified Animals Needed In UK
Read More
ScanBalt BioRegion Looking To Create Global Biotech Region
Read More
Other News To Note
Read More